Your session is about to expire
← Back to Search
Peer Navigation for Prostate Cancer
N/A
Waitlist Available
Led By Jackie Bender, PhD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Has been diagnosed with local, locally advanced or stable metastatic PC
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights
Study Summary
This trial will test whether a new cancer patient navigation program, which pairs patients with trained peer navigators, can improve quality of life, social support and health care service use for men with prostate cancer.
Who is the study for?
This trial is for Canadian men who've recently finished prostate cancer treatment within the last 3 months, can read and speak English, and have an email or are willing to create one. It's not for those with advanced metastatic disease, receiving palliative care, or unwilling to be randomly assigned.Check my eligibility
What is being tested?
The study tests a web-based peer navigation program where men with prostate cancer receive guidance from trained peers online. The goal is to see if this support improves their quality of life and health management compared to usual care plus website information access.See study design
What are the potential side effects?
Since this trial involves a support program rather than medication, traditional side effects like you'd expect from drugs aren't applicable. However, participants may experience emotional impacts from discussing sensitive health issues.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My prostate cancer is not spreading rapidly.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Patient Activation at 3 months
Secondary outcome measures
Change in Anxiety
Change in Depression
Change in Fear of Cancer Recurrence
+5 moreOther outcome measures
Intervention cost
Quality-adjusted life year
Total healthcare costs
Trial Design
2Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
Participants assigned to the intervention arm will receive the True North Peer Navigation intervention.
Group II: Active Waitlist ControlExperimental Treatment1 Intervention
Participants assigned to the control arm will receive usual care and access to an online health resource library. After completion of the study, they will receive the True North Peer Navigation intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Peer navigation
2016
Completed Phase 4
~220
Find a Location
Who is running the clinical trial?
University of British ColumbiaOTHER
1,413 Previous Clinical Trials
2,466,777 Total Patients Enrolled
10 Trials studying Prostate Cancer
2,955 Patients Enrolled for Prostate Cancer
Canadian Cancer Society (CCS)OTHER
78 Previous Clinical Trials
37,561 Total Patients Enrolled
7 Trials studying Prostate Cancer
7,441 Patients Enrolled for Prostate Cancer
Walnut FoundationUNKNOWN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have an email address or am willing to create one.I am not open to being randomly assigned to a treatment group.I finished my treatment less than 3 months ago.I am receiving care focused on relieving symptoms and improving quality of life.My prostate cancer is not spreading rapidly.My cancer has spread to other parts of my body.
Research Study Groups:
This trial has the following groups:- Group 1: Active Waitlist Control
- Group 2: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any recruitment opportunities for this research endeavor?
"Aye, clinicaltrials.gov corroborates that this experiment is actively enrolling volunteers. It was first published on May 13th 2022 and the guidelines were amended as recently as the 17th of May 2022. 240 participants are needed across 5 different locations."
Answered by AI
How far-reaching is the scope of this trial?
"At present, there are 5 medical sites recruiting for this study. They can be found in Toronto, Halifax and Sydney as well as other cities spread across the region. To reduce travel burden, it is advisable to select a location close you if possible."
Answered by AI
What is the cap on enrolling participants in this medical experiment?
"Affirmative. Clinicaltrials.gov records confirm that the trial, initially posted on May 13th 2022, is currently recruiting participants. This medical study seeks 240 patients from 5 different sites."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger